Design Considerations Used to Develop Clinical Reporting Software

Most drug development organizations have two basic needs.  The first need is to standardize the reporting and second, to streamline the reporting process. SAS-generated reports are a
key component of most clinical study reports that are included in a regulatory submission.  The reporting of most clinical data is similar from study to study and therefore can be standardized.  This standardization creates an opportunity for SAS macro-driven reporting.